According to the present invention, there are provided a method for producing a human T cell, which comprises the steps of inducing an iPS cell from a human T cell, and differentiating the iPS cell into a T cell； a pharmaceutical composition comprising the T cell produced by the method； and a method for cell-based immunotherapy using the method.
